Core Viewpoint - Ningbo Lixian Intelligent Technology Co., Ltd. has completed a Pre-A round of financing, which will be used to build a high-end optical imaging innovation platform for biomedicine, accelerating the development and market expansion of several self-developed microscopy instruments and biomedical solutions [2] Group 1: Company Overview - Lixian Intelligent Technology focuses on high-end optical imaging systems and comprehensive solutions for biomedicine, with a core team from prestigious institutions such as Hong Kong University of Science and Technology, Fudan University, and the Chinese Academy of Sciences [3] - The company aims to transform cutting-edge microscopy technology into scalable research and industrial tools, covering various typical scenarios from basic to applied research [3] Group 2: Product Highlights - One of the core products is the iSTORM super-resolution imaging system, which achieves approximately 20 nanometer resolution and is used for live cell and single-molecule imaging, applicable in cell molecular structure analysis and molecular dynamic process tracking [3] - The product lines include: - Cellaview series for live cell imaging, allowing continuous, non-destructive monitoring in cell culture environments [7] - INCount series for automated analysis of cell quantity and status, targeting research institutions and biopharmaceutical companies [9] Group 3: Financing and Future Focus - The financing will support ongoing investment in high-end imaging core technologies and market expansion, with the investor emphasizing the long-term importance of life science instruments [10] - The high-end microscopy equipment market is advancing in technology and market demand, with Lixian Intelligent Technology's progress in product engineering, market validation, and scalable delivery to be closely monitored [10]

→点击免费限量礼盒 摘要 ： 环岛生物位于湖北青创园（光谷）示范园，是一家研发和生产生物仪器和实验室设备的初创公司。公司自主研发的几款产品 发售不到一个月，就收获了来自十余个国家的订单，今年公司总体销售额已达1200多万元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 "我们自主研发的几款产品发售不到一个月，就收获了来自国内和俄罗斯、德国、新加坡、巴基斯坦等十余个国家的订 单，展现出不错的市场潜力。" 11月3 0日，环岛生物科技（武汉）有限公司（以下简称环岛生物）总经理李敏介绍， 今年该公司总体销售额已达1 2 0 0多万元 。 环岛生物科技（武汉）有限公司总 经理李敏展 示植入式无线 微型生理信号采集器 环岛生物位于湖北青创园（光谷）示范园，是一家研发和生产生物仪器和实验室设备的初创公司。从园区的工位起步到 如今以颠覆性产品叩开全球市场的大门，这家企业正以其扎实的技术创新为实现科研仪器国产化持续奋进，也让世界看 到了中国生物科技领域的硬核实力。 相较于国外进口设备， 环岛生物自主研发的动物生理无线遥测系统优势显著。 传统进口设备是在 ...

Core Insights - The company, HuanDao Biotechnology (Wuhan) Co., Ltd., has received orders from over ten countries, including Russia, Germany, Singapore, and Pakistan, within a month of launching several self-developed products, indicating strong market potential [1] - The company has achieved total sales exceeding 12 million yuan this year, showcasing its growth trajectory [1] Company Overview - HuanDao Biotechnology is a startup located in Hubei Qingchuang Park (Optics Valley), focusing on the research and production of biological instruments and laboratory equipment [2] - The company aims to achieve domestic production of scientific research instruments through solid technological innovation, demonstrating China's capabilities in the biotechnology sector [2] Product Innovation - The company's self-developed animal physiological wireless telemetry system offers significant advantages over traditional imported devices, allowing real-time monitoring of multiple animals without interference, thus improving experimental efficiency [2] - The system can transition from basic research applications to the public health sector, with portable wireless monitoring devices for ECG, EEG, temperature, and blood glucose [3] - Other innovative products launched in October include the ultrasound stimulation system and programmable microelectrode puller, which represent breakthroughs in non-invasive neural regulation and electrode fabrication for scientific research [3] Market Positioning - HuanDao Biotechnology emphasizes that domestic scientific research instruments should not only be competitively priced but also match international brands in performance and reliability [4] - The recognition from various domestic and international research teams validates the company's commitment to independent research and development [4]